Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281411
Status:
COMPLETED
Last Update Posted:
2018-02-15
First Post:
2006-01-20
Brief Title:
Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial
Sponsor:
Clinical Research Office Imaging Division
Organization:
UMC Utrecht
Study Overview
Official Title:
Follow-up Study of Endovascular Abdominal Aortic Aneurysm Treatment
Status:
COMPLETED
Status Verified Date:
2016-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
After endovascular abdominal aortic aneurysm repair life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow For this reason aneurysm diameter and the presence of endoleaks is evaluated with CT angiography yearly after Endovascular Aneurysm Repair EVAR
The aim of this study is to investigate the value of MRA examinations for the follow-up of these patients The advantages of MRA with respect to CTA are no use of ionizing radiation use of less nephrotoxic contrast agents
The aim of this study is to investigate the value of MRA examinations for the follow-up of these patients The advantages of MRA with respect to CTA are no use of ionizing radiation use of less nephrotoxic contrast agents
Detailed Description:
The FEAT trial Follow-up of Endovascular Aneurysm Treatment is designed as a prospective single-center follow-up study 100 Patients will be enrolled in this study These patients will undergo additional MRA-examinations the day before EVAR the day after EVAR 6 months and 1 year after EVAR These patients also participate in the conventional CTA follow-up scheme which comprises a pre- and post-operative CTA and a CTA yearly thereafter Coagulation parameters in the blood will be measured before and 1 year after EVAR
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None